27.02
price up icon3.25%   0.805
 
loading
Precedente Chiudi:
$26.21
Aprire:
$26.42
Volume 24 ore:
168.31K
Relative Volume:
0.30
Capitalizzazione di mercato:
$793.71M
Reddito:
$17.16M
Utile/perdita netta:
$-163.62M
Rapporto P/E:
-4.4433
EPS:
-6.08
Flusso di cassa netto:
$-121.61M
1 W Prestazione:
+0.75%
1M Prestazione:
+18.59%
6M Prestazione:
+62.73%
1 anno Prestazione:
-26.78%
Intervallo 1D:
Value
$26.16
$27.38
Intervallo di 1 settimana:
Value
$25.48
$27.46
Portata 52W:
Value
$12.21
$41.31

Anaptysbio Inc Stock (ANAB) Company Profile

Name
Nome
Anaptysbio Inc
Name
Telefono
858-362-6295
Name
Indirizzo
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Name
Dipendente
136
Name
Cinguettio
@anaptysbio
Name
Prossima data di guadagno
2024-11-08
Name
Ultimi documenti SEC
Name
ANAB's Discussions on Twitter

Confronta ANAB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ANAB
Anaptysbio Inc
27.02 782.40M 17.16M -163.62M -121.61M -6.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.21 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.05 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.00 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
574.20 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.35 29.19B 3.81B -644.79M -669.77M -6.24

Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-04 Aggiornamento H.C. Wainwright Neutral → Buy
2025-02-04 Iniziato Wolfe Research Outperform
2024-12-11 Downgrade H.C. Wainwright Buy → Neutral
2024-12-02 Downgrade BTIG Research Buy → Neutral
2024-07-22 Iniziato H.C. Wainwright Buy
2024-07-19 Aggiornamento JP Morgan Neutral → Overweight
2024-04-16 Iniziato Leerink Partners Outperform
2024-04-11 Iniziato Wells Fargo Overweight
2024-03-12 Aggiornamento Wedbush Neutral → Outperform
2024-02-26 Iniziato BTIG Research Buy
2024-02-21 Iniziato Stifel Buy
2024-02-16 Iniziato Piper Sandler Overweight
2023-05-22 Aggiornamento JP Morgan Underweight → Neutral
2023-05-18 Iniziato TD Cowen Outperform
2023-01-06 Downgrade Raymond James Outperform → Mkt Perform
2022-11-01 Aggiornamento Guggenheim Neutral → Buy
2022-09-19 Ripresa H.C. Wainwright Buy
2022-09-13 Downgrade Truist Buy → Hold
2022-09-01 Iniziato Raymond James Outperform
2022-03-22 Downgrade Guggenheim Buy → Neutral
2021-06-22 Iniziato H.C. Wainwright Buy
2021-05-21 Iniziato UBS Neutral
2021-03-16 Aggiornamento Truist Hold → Buy
2021-03-09 Downgrade Wedbush Outperform → Neutral
2021-03-08 Downgrade JP Morgan Overweight → Underweight
2021-02-11 Aggiornamento JP Morgan Underweight → Overweight
2020-10-27 Aggiornamento Wedbush Neutral → Outperform
2020-10-14 Aggiornamento Guggenheim Neutral → Buy
2019-11-08 Downgrade JP Morgan Overweight → Underweight
2019-11-08 Downgrade Jefferies Buy → Hold
2019-11-08 Downgrade SunTrust Buy → Hold
2019-11-08 Downgrade Wedbush Outperform → Neutral
2019-06-21 Downgrade Credit Suisse Outperform → Neutral
2019-06-21 Downgrade Stifel Buy → Hold
2018-12-20 Iniziato H.C. Wainwright Buy
2018-11-21 Iniziato JP Morgan Overweight
2018-07-19 Iniziato Credit Suisse Outperform
2018-04-04 Downgrade RBC Capital Mkts Outperform → Sector Perform
2018-03-27 Reiterato Stifel Buy
2018-03-06 Reiterato Stifel Buy
2018-02-15 Reiterato SunTrust Buy
2018-01-23 Reiterato Credit Suisse Outperform
2017-11-15 Iniziato SunTrust Buy
2017-11-09 Iniziato Jefferies Buy
2017-10-11 Reiterato RBC Capital Mkts Outperform
2017-09-15 Iniziato RBC Capital Mkts Outperform
Mostra tutto

Anaptysbio Inc Borsa (ANAB) Ultime notizie

pulisher
Jul 22, 2025

AnaptysBio Inc. Stock Analysis and ForecastConsistent triple-digit returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about AnaptysBio Inc. stockHigh-yield portfolio picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How AnaptysBio Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Is AnaptysBio Inc. a good long term investmentConsistent high-yield stocks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

What drives AnaptysBio Inc. stock priceFree Stock Market Knowledge Sharing - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 16, 2025

AnaptysBio, Inc.'s (NASDAQ:ANAB) Share Price Not Quite Adding Up - simplywall.st

Jul 16, 2025
pulisher
Jul 15, 2025

What makes AnaptysBio Inc. stock price move sharplyShort Squeeze Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why AnaptysBio Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

AnaptysBio (ANAB) Soars 2.86% on Two Sigma Stake Increase - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

AnaptysBio: Potential Promise, But Some Cause For Skepticism (NASDAQ:ANAB) - Seeking Alpha

Jul 14, 2025
pulisher
Jul 14, 2025

(ANAB) Trading Report - news.stocktradersdaily.com

Jul 14, 2025
pulisher
Jul 12, 2025

AnaptysBio (NASDAQ:ANAB) Stock Price Up 7.6%What's Next? - MarketBeat

Jul 12, 2025
pulisher
Jul 07, 2025

Moody Aldrich Partners LLC Acquires New Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Jul 07, 2025
pulisher
Jul 06, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Director Sells $493,202.25 in Stock - MarketBeat

Jul 06, 2025
pulisher
Jul 04, 2025

AnaptysBio, Inc. (ANAB) Stock Analysis: A High-Risk, High-Reward Bet with a 79% Potential Upside - DirectorsTalk Interviews

Jul 04, 2025
pulisher
Jul 03, 2025

(ANAB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jul 03, 2025
pulisher
Jul 03, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Jul 03, 2025
pulisher
Jun 25, 2025

Farther Finance Advisors LLC Increases Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Jun 25, 2025
pulisher
Jun 24, 2025

GAMMA Investing LLC Acquires New Stake in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Jun 24, 2025
pulisher
Jun 23, 2025

When the Price of (ANAB) Talks, People Listen - news.stocktradersdaily.com

Jun 23, 2025
pulisher
Jun 23, 2025

Rhumbline Advisers Grows Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Jun 23, 2025
pulisher
Jun 19, 2025

Assenagon Asset Management S.A. Has $4.51 Million Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Jun 19, 2025
pulisher
Jun 18, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Holdings Trimmed by Bank of America Corp DE - MarketBeat

Jun 18, 2025
pulisher
Jun 17, 2025

AnaptysBio Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 17, 2025
pulisher
Jun 15, 2025

Bank of America Corp DE Lowers Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Purchased by California State Teachers Retirement System - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

FMR LLC Significantly Reduces Stake in AnaptysBio Inc - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Stocks With Rising Relative Price Strength: AnaptysBio - Investor's Business Daily

Jun 12, 2025
pulisher
Jun 11, 2025

JPMorgan Sees AnaptysBio (ANAB) as Undervalued Due to Rosnilimab - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Shareholders May Be More Conservative With AnaptysBio, Inc.'s (NASDAQ:ANAB) CEO Compensation For Now - simplywall.st

Jun 11, 2025
pulisher
Jun 10, 2025

New RA Drug Shown to Work, Be Safe - streetwisereports.com

Jun 10, 2025
pulisher
Jun 10, 2025

AnaptysBio: Rosnilimab's RA Data Sets The Stage For Blockbuster Potential (NASDAQ:ANAB) - Seeking Alpha

Jun 10, 2025
pulisher
Jun 09, 2025

ANAB Schedules June 9 Conference Call with JPMorgan | ANAB Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Brokerages Set AnaptysBio, Inc. (NASDAQ:ANAB) Price Target at $42.38 - MarketBeat

Jun 09, 2025
pulisher
Jun 08, 2025

AnaptysBio (NASDAQ:ANAB) Trading Down 4.5%Time to Sell? - MarketBeat

Jun 08, 2025
pulisher
Jun 08, 2025

AnaptysBio (NASDAQ:ANAB) Upgraded by HC Wainwright to "Buy" Rating - MarketBeat

Jun 08, 2025
pulisher
Jun 07, 2025

AnaptysBio (NASDAQ:ANAB) Shares Gap UpHere's What Happened - MarketBeat

Jun 07, 2025

Anaptysbio Inc Azioni (ANAB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Anaptysbio Inc Azioni (ANAB) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
RENTON HOLLINGS
Director
Jul 02 '25
Sale
23.57
20,925
493,191
4,965
$22.77
price up icon 4.50%
$36.02
price down icon 0.12%
$102.58
price down icon 0.21%
$27.91
price up icon 5.14%
$113.56
price up icon 1.86%
biotechnology ONC
$295.56
price down icon 0.03%
Capitalizzazione:     |  Volume (24 ore):